Article Information
History
- May 8, 2020.
Article Versions
- You are currently viewing Version 1 of this article (May 8, 2020 - 02:31).
- Version 2 (July 21, 2020 - 11:06).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Bernhard Kerschberger1,2,
- Andrew Boulle2,
- Rudo Kuwengwa3,
- Iza Ciglenecki4 and
- Michael Schomaker2,5,*
- 1Médecins Sans Frontières (Operational Centre Geneva), Mbabane, Eswatini
- 2Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
- 3Eswatini National AIDS Programme (ENAP), Ministry of Health, Mbabane, Eswatini
- 4Médecins Sans Frontières (Operational Centre Geneva), Geneva, Switzerland
- 5Institute of Public Health, Medical Decision Making and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria
- ↵*Corresponding author; email: michael.f.schomaker{at}gmail.com
Posted May 08, 2020.
The impact of same-day antiretroviral therapy initiation under the WHO Treat-All policy
